Assad Khalid
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
-
- Medicinal Plants and Neuroprotection
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 3
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Bilge Şener (2 shared papers)Muhammad Iqbal Choudhary (3 shared papers)İlkay Erdoğan Orhan (1 shared paper)Atta‐ur Rahman (2 shared papers)Yoshisuke Tsuda (1 shared paper)Muhammad Nadeem Akhtar (1 shared paper)Masood Parvez (1 shared paper)Ayako Ebata (1 shared paper)
- Journals
- EClinicalMedicine (1 paper)Chemical and Pharmaceutical Bulletin (1 paper)International Journal of Biological Macromolecules (1 paper)The Lancet Diabetes & Endocrinology (1 paper)Journal of Ethnopharmacology (1 paper)
- Partner nations
- PakistanTürkiyeSaudi Arabia
In The Last Decade
Assad Khalid
10 papers receiving 418 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 135
- Complementary and alternative medicine 72
- Applied Microbiology and Biotechnology 8
- Plant Science 118
- Biochemistry 20
Countries citing papers authored by Assad Khalid
This map shows the geographic impact of Assad Khalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assad Khalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assad Khalid more than expected).
Fields of papers citing papers by Assad Khalid
This network shows the impact of papers produced by Assad Khalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assad Khalid. The network helps show where Assad Khalid may publish in the future.
Co-authors
The 16 scholars most cited alongside Assad Khalid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 277 | |
| 2 | 2002 | 62 | |
| 3 | 2021 | 38 | |
| 4 | 2023 | 25 | |
| 5 | 2024 | 24 | |
| 6 | 2024 | 7 | |
| 7 | 1998 | 5 | |
| 8 | 2016 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2010 | 1 |
About Assad Khalid
Assad Khalid is a scholar working on Pharmacology, Infectious Diseases, Applied Microbiology and Biotechnology, Periodontics and Pharmacology, having authored 10 papers that have together received 444 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (3 papers), COVID-19 Clinical Research Studies (2 papers), Oral microbiology and periodontitis research (1 paper), Epigenetics and DNA Methylation (1 paper), Pharmaceutical Economics and Policy (1 paper), Phytochemical Studies and Bioactivities (1 paper), Antibiotic Use and Resistance (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Pharmacology (135 citations), Complementary and alternative medicine (72 citations), Applied Microbiology and Biotechnology (8 citations), Plant Science (118 citations) and Biochemistry (20 citations). Assad Khalid has collaborated with scholars based in Pakistan, Türkiye and Saudi Arabia. Frequent co-authors include Bilge Şener, Muhammad Iqbal Choudhary, İlkay Erdoğan Orhan, Atta‐ur Rahman, Yoshisuke Tsuda, Muhammad Nadeem Akhtar, Masood Parvez, Ayako Ebata, Jehangir Cama and Christopher Gerard Dowson. Their work appears in journals such as EClinicalMedicine, Chemical and Pharmaceutical Bulletin, International Journal of Biological Macromolecules, The Lancet Diabetes & Endocrinology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.